Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer PatientsAbimbola F. Onyia, Solomon O. Rotimi, Adewumi Alabi et al.|Technology in Cancer Research & Treatment|2025Cited by 4
Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patientsAbimbola F. Onyia, AbdulRazzaq Oluwagbemiga Lawal, Chidiebere Ogo et al.|Cancer Genetics|2025Cited by 2
Author response for "Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients"Abimbola F. Onyia, Solomon O. Rotimi, Paul Jibrin et al.|Unknown|2024Cited by 0